M. Li

Also affiliated with AbbVie (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “918O Telisotuzumab adizutecan (ABBV-400; Temab-A) in patients with MET-amplified (MET-amp) advanced solid tumors: Results from a phase I study”.

918O Telisotuzumab adizutecan (ABBV-400; Temab-A) in patients with MET-amplified (MET-amp) advanced solid tumors: Results from a phase I study

Annals of Oncology(2025)10.1016/j.annonc.2025.08.1487

N/A

0DataRank · unranked

2 citations

Yasutoshi Kuboki, John H. Strickler, Kanwal Pratap Singh Raghav, Antoine Hollebecque, D.H. Lee +15 more